Attached files

file filename
EX-99.1 - EX-99.1 - ARTHROCARE CORPa12-11137_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 2, 2012

 

ARTHROCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

0-027422

 

94-3180312

(State or other jurisdiction

 

(Commission File Number)

 

(I.R.S. Employer Identification

of Incorporation)

 

 

 

Number)

 

7000 W. William Cannon, Building One

Austin, TX  78735

(Address of principal executive offices, including zip code)

 

(512) 391-3900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 14e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02  Results of Operations

 

On May 2, 2012, ArthroCare Corporation issued a press release announcing its financial results for the quarter ended March 31, 2012.  The press release, a copy of which is furnished as exhibit 99.1 to this report, is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits

 

Exhibits

 

Exhibit
Number

 

Title

99.1

 

Press release dated May 2, 2012.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ARTHROCARE CORPORATION

 

 

 

 

Date: May 2, 2012

By:

/s/ David Fitzgerald

 

David Fitzgerald

 

President and Chief Executive Officer

 

3



 

ARTHROCARE CORPORATION

 

INDEX TO EXHIBITS

 

Exhibit
Number

 

Title

 

 

 

99.1

 

Press release dated May 2, 2012

 

4